miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines
miR-122, a hepato-specific microRNA (miRNA), is frequently down-regulated in human hepatocellular carcinoma (HCC). In an effort to identify novel miR-122 targets, we performed an in silico analysis and detected a putative binding site in the 3′-untranslated region (3′-UTR) of Bcl-w, an anti-apoptoti...
Saved in:
Published in | Biochemical and biophysical research communications Vol. 375; no. 3; pp. 315 - 320 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
24.10.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | miR-122, a hepato-specific microRNA (miRNA), is frequently down-regulated in human hepatocellular carcinoma (HCC). In an effort to identify novel
miR-122 targets, we performed an
in silico analysis and detected a putative binding site in the 3′-untranslated region (3′-UTR) of
Bcl-w, an anti-apoptotic Bcl-2 family member. In the HCC-derived cell lines, Hep3B and HepG2, we confirmed that
miR-122 modulates
Bcl-w expression by directly targeting binding site within the 3′-UTR. The cellular mRNA and protein levels of
Bcl-w were repressed by elevated levels of
miR-122, which subsequently led to reduction of cell viability and activation of caspase-3. Thus,
Bcl-w is a direct target of
miR-122 that functions as an endogenous apoptosis regulator in these HCC-derived cell lines. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0006-291X 1090-2104 |
DOI: | 10.1016/j.bbrc.2008.07.154 |